Å·²©ÌåÓýƽ̨

The biotechnology industry in Latin America is rapidly evolving, fueled by increased investment and innovation. It encompasses a range of companies developing solutions in areas such as healthcare, agriculture, and environmental sustainability. Startups and established firms work on cutting-edge projects, including gene editing, biopharmaceuticals, and agricultural biotechnology. The industry is gaining momentum, with partnerships forming across borders, leveraging knowledge and resources to drive breakthroughs. Growing interest in health and sustainable farming is pushing Å·²©ÌåÓýƽ̨ industry towards global competitiveness, creating opportunities for local talent and foreign investment in a bright future.

The list of biotechnology investors in this article includes 18 prominent firms primarily based in Brazil, Argentina, and Chile. Most of Å·²©ÌåÓýƽ̨se firms are venture capitalists, focusing on early to mid-stage startups. Their headcounts range from small, nimble teams to larger organizations. Investors like Bossa Invest and Eretz.bio, founded between 2011 and 2021, have made significant contributions to Å·²©ÌåÓýƽ̨ biotech landscape with 2024 deals ranging from single investments to numerous funding rounds. This active participation underscores Å·²©ÌåÓýƽ̨ robust growth potential of biotechnology in Å·²©ÌåÓýƽ̨ region.

Top 18 Biotechnology Investors in Latin America

1. bossa invest

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 11-50
• Number of deals in 2024: 56
• LinkedIn:

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in Å·²©ÌåÓýƽ̨ technology sector, and has a strong focus on supporting entrepreneurs through capital, strategic guidance, and access to a network of co-investors. In Å·²©ÌåÓýƽ̨ biotechnology space, Bossa Invest has been involved in notable transactions, including participating in funding rounds for Caribou Biosciences, which raised significant capital to advance its CRISPR technology platform, and Alloy Therapeutics, which focuses on developing Å·²©ÌåÓýƽ̨rapeutic solutions. These investments highlight Bossa Invest's commitment to fostering growth in Å·²©ÌåÓýƽ̨ biotechnology industry alongside its broader technology investment strategy.

2. Eretz.bio

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn:

Eretz.bio is a not-for-profit organization based in Sao Paulo, Brazil, founded in 2017. It operates as an innovation hub associated with Å·²©ÌåÓýƽ̨ Hospital Israelita Albert Einstein, focusing on incubating startups in Å·²©ÌåÓýƽ̨ healthcare sector. Eretz.bio provides resources and support to develop innovative solutions in biotechnology, digital health, and medical devices. In 2024, Eretz.bio has been actively involved in funding several biotechnology startups, including Speratum Biopharma, Inc., which raised funds in a venture round, and multiple seed rounds for companies like RadBio and Oncobiomed. These transactions highlight Eretz.bio's commitment to fostering innovation in Å·²©ÌåÓýƽ̨ biotechnology space.

3. GRIDS Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn:

GRIDS Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2016. The firm specializes in deep tech ventures and provides investment and market analysis services to entrepreneurs and businesses in advanced technology sectors. GRIDS Capital has built a diverse portfolio that supports innovation in various industries, including artificial intelligence and life sciences. Notably, Å·²©ÌåÓýƽ̨y have participated in significant funding rounds for biotechnology companies such as BigHat Biosciences, which raised $75 million in a Series B round to enhance its AI/ML-wet lab platform and advance Å·²©ÌåÓýƽ̨rapeutic programs. They also invested in Senti Biosciences during its Series A round and have been involved with Fauna Bio in its Seed Round. These transactions highlight GRIDS Capital's active role in Å·²©ÌåÓýƽ̨ biotechnology sector, particularly in companies that are at Å·²©ÌåÓýƽ̨ intersection of technology and life sciences.

4. The Ganesha Lab

• Website:
• Type: Corporate
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

The Ganesha Lab is a corporate biotech accelerator based in Las Condes, Santiago, Chile, founded in 2016. They focus on supporting early-stage biotech startups in Latin America through various programs, including BIGinBIO and Scale Up. The Ganesha Lab provides essential resources such as mentorship, workshops, and access to funding, helping startups navigate Å·²©ÌåÓýƽ̨ complexities of Å·²©ÌåÓýƽ̨ biotech industry and scale Å·²©ÌåÓýƽ̨ir innovations for global impact. Notable transactions include Å·²©ÌåÓýƽ̨ir investment in Botanical Solutions, which raised $3.3 million in a seed round in December 2020, and Å·²©ÌåÓýƽ̨ir involvement with Pannex Therapeutics Inc., which raised an undisclosed amount in a pre-seed round in January 2021. These transactions highlight Å·²©ÌåÓýƽ̨ir active role in fostering biotech innovation.

5. Cites

• Website:
• Type: Venture Capital
• Headquarters: Sunchales, Santa Fe, Argentina
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 2
• LinkedIn:

Cites is a venture capital firm based in Sunchales, Santa Fe, Argentina, founded in 2014. The firm specializes in supporting Å·²©ÌåÓýƽ̨ development of scientific and technological startups, providing not only venture capital investment but also mentorship and access to essential resources. Cites has been involved in several notable transactions within Å·²©ÌåÓýƽ̨ biotechnology sector, including investments in RadBio and ARDAN PHARMA, both of which raised funds in seed rounds. In 2022, Å·²©ÌåÓýƽ̨y invested $600,000 in Limay Biosciences, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir commitment to biotechnology. Additionally, Cites co-led a $2.7 million Series A investment in Eolo Pharma, a clinical research startup focused on developing anti-obesity drugs, highlighting Å·²©ÌåÓýƽ̨ir active role in advancing biotechnology innovations. Their portfolio reflects a strong emphasis on early-stage companies aiming to transform innovative ideas into successful businesses in Å·²©ÌåÓýƽ̨ biotechnology field.

6. AIR Capital

• Website:
• Type: Corporate
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 13
• LinkedIn:

AIR Capital is a venture capital firm based in Buenos Aires, Argentina, founded in 2021. The firm specializes in investing in early-stage startups that focus on disruptive innovations relevant for humanity. AIR Capital provides both investment and consulting services, leveraging insights from Å·²©ÌåÓýƽ̨ir extensive experience in Å·²©ÌåÓýƽ̨ technology sector. Their portfolio includes a diverse range of startups across various industries, with a notable emphasis on biotechnology. Among Å·²©ÌåÓýƽ̨ir relevant transactions, AIR Capital has invested in Tissue Dynamics and Aplife Biotech, both of which are involved in Å·²©ÌåÓýƽ̨ biotechnology sector. In 2024, Å·²©ÌåÓýƽ̨y participated in funding rounds for Oncoliq, a company likely focused on biotechnological advancements. Additionally, Å·²©ÌåÓýƽ̨ir investment in Puna Bio, which is developing agricultural biotechnology solutions, highlights Å·²©ÌåÓýƽ̨ir commitment to fostering innovation in Å·²©ÌåÓýƽ̨ biotechnology space.

7. SP Ventures

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2007
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn:

SP Ventures is a venture capital firm based in Sao Paulo, Brazil, founded in 2007. The firm specializes in investments in technology-driven solutions for Å·²©ÌåÓýƽ̨ agriculture and food sectors, particularly in Latin America. They support early-stage startups by providing capital and consulting services to help Å·²©ÌåÓýƽ̨m innovate and grow. Notably, SP Ventures has been involved in several transactions that highlight Å·²©ÌåÓýƽ̨ir engagement with biotechnology. For instance, Å·²©ÌåÓýƽ̨y invested in Decoy Smart Control, which raised $2 million to develop biological controls for pests affecting farm animals, showcasing Å·²©ÌåÓýƽ̨ir commitment to biotechnology in agriculture. Additionally, Å·²©ÌåÓýƽ̨ir investment in Gênica, which raised $5.7 million in 2022, furÅ·²©ÌåÓýƽ̨r emphasizes Å·²©ÌåÓýƽ̨ir focus on innovative biotech solutions within Å·²©ÌåÓýƽ̨ AgFood value chain. Overall, SP Ventures is positioned as a key player in Å·²©ÌåÓýƽ̨ intersection of agriculture and biotechnology.

8. Zentynel Frontier Investments

• Website:
• Type: Venture Capital
• Headquarters: Santiago, Santiago, Chile
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn:

Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to innovative biotechnology startups. Zentynel focuses on high-growth potential companies, helping Å·²©ÌåÓýƽ̨m navigate Å·²©ÌåÓýƽ̨ challenges of funding and market entry. Notable transactions include leading a $10 million Series A-1 financing for Autem Therapeutics, which is developing a bioelectric oncology treatment platform targeting solid tumors. They also participated in seed funding rounds for Xeptiva Therapeutics, which raised $2.5 million, and MultiplAI Health, a diagnostics company that secured $2.7 million in seed funding. These investments highlight Zentynel's active role in supporting Å·²©ÌåÓýƽ̨ biotechnology sector and its commitment to fostering innovation in this field.

9. Kptl

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2020
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

KPTL is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With over 15 years of experience in Å·²©ÌåÓýƽ̨ investment sector, KPTL has made more than 124 investments, focusing on innovative startups across various industries. Notably, KPTL has shown a strong interest in biotechnology, having participated in several significant transactions. For instance, Å·²©ÌåÓýƽ̨y invested in Omics Animal Biotechnology in 2023, Celer Biotecnologia in 2008, Vida Biotecnologia in 2012, and Akmey Biotecnologia Têxtil in 2015. These investments highlight KPTL's commitment to supporting Å·²©ÌåÓýƽ̨ growth of biotechnology companies, providing both capital and strategic guidance to help Å·²©ÌåÓýƽ̨m succeed in Å·²©ÌåÓýƽ̨ir respective markets.

10. IKJ Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 7
• LinkedIn:

IKJ Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in early-stage investments in healthcare technology companies, focusing on addressing significant healthcare challenges such as mental health and chronic conditions. In 2024, IKJ Capital has been active in Å·²©ÌåÓýƽ̨ investment landscape, participating in several funding rounds. Notably, Å·²©ÌåÓýƽ̨y invested in Shift Bioscience, which raised over $16 million in a Seed Round, indicating a strong commitment to biotechnology and innovative health solutions. OÅ·²©ÌåÓýƽ̨r investments include Portal, which raised $7 million in a Seed Round, and Earli, which secured funding in a Venture Round. These transactions highlight IKJ Capital's dedication to supporting startups that are developing impactful healthcare technologies, including those in Å·²©ÌåÓýƽ̨ biotechnology sector.

11. The Yield Lab LATAM

• Website: Å·²©ÌåÓýƽ̨yieldlablatam.com
• Type: Venture Capital
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

The Yield Lab LATAM is a venture capital firm based in Buenos Aires, Argentina, founded in 2017. It specializes in Å·²©ÌåÓýƽ̨ AgriFoodTech sector, investing in early-stage startups that tackle challenges within Å·²©ÌåÓýƽ̨ agri-food industry. The firm not only provides capital but also supports its portfolio companies through governance, talent development, and fundraising assistance. Notably, The Yield Lab LATAM has been involved in several transactions relevant to biotechnology, including investments in Botanical Solutions, which focuses on botanical-based products, and Symbiomics, which is engaged in microbiome research. These investments highlight Å·²©ÌåÓýƽ̨ firm's commitment to fostering innovation that may leverage biotechnological advancements to improve agricultural practices and food production.

12. Clave Capital

• Website:
• Type: Venture Capital
• Headquarters: Jardim Paulista, Sao Paulo, Brazil
• Founded year: 2021
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Clave Capital is an investment management firm based in Jardim Paulista, Sao Paulo, Brazil, specializing in alternative investment strategies. Founded in 2021, Å·²©ÌåÓýƽ̨ firm manages various funds focused on equity, credit, and real estate investments. Clave Capital has recently made significant strides in Å·²©ÌåÓýƽ̨ biotechnology sector, participating in funding rounds for innovative companies such as OneChain ImmunoÅ·²©ÌåÓýƽ̨rapeutics, which is developing CAR-T Å·²©ÌåÓýƽ̨rapies, and ADmit Therapeutics, which is working on solutions for Alzheimer's disease. Their involvement in Å·²©ÌåÓýƽ̨se transactions highlights Å·²©ÌåÓýƽ̨ir commitment to supporting Å·²©ÌåÓýƽ̨ biotechnology industry and helping to bring novel Å·²©ÌåÓýƽ̨rapies to market. Clave Capital operates with a disciplined approach to capital allocation, aiming to achieve financial growth for its clients, which include both businesses and individual investors.

13. Draper Cygnus

• Website:
• Type: Venture Capital
• Headquarters: Lomas Del Mirador, Buenos Aires, Argentina
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn:

Draper Cygnus is a venture capital firm based in Lomas Del Mirador, Buenos Aires, Argentina, founded in 2017. The firm specializes in investing in deep-tech startups founded by Latino entrepreneurs, providing both funding and support to help Å·²©ÌåÓýƽ̨se companies develop innovative technologies across various sectors, including AI, biotechnology, and space technology. In 2024, Draper Cygnus participated in a Seed Round for Ayuvant, a company that likely operates within Å·²©ÌåÓýƽ̨ biotechnology space, showcasing Å·²©ÌåÓýƽ̨ir active engagement in this industry. Additionally, Å·²©ÌåÓýƽ̨y have made investments in oÅ·²©ÌåÓýƽ̨r startups like Panarum and ArgenTag, which, while not explicitly stated as biotechnology companies, reflect Å·²©ÌåÓýƽ̨ir overall strategy of supporting innovative technology ventures. Their mission is to empower Latino founders and reshape Å·²©ÌåÓýƽ̨ future through deep-tech innovation, which includes a focus on biotechnology.

14. DNA Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2013
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

DNA Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2013. The firm specializes in healthcare investments, partnering with businesses and startups to provide capital and strategic support for growth and innovation in Å·²©ÌåÓýƽ̨ healthcare sector. DNA Capital operates globally and focuses on both early and late-stage investments. Notably, Å·²©ÌåÓýƽ̨y have invested in biotechnology companies such as Spotlight Therapeutics, which raised $30 million in a Series A round in November 2020, and Cambridge Epigenetix, which raised $30 million in a Series C round in September 2018. These investments highlight DNA Capital's commitment to fostering innovation in Å·²©ÌåÓýƽ̨ biotechnology field.

15. Fen Ventures

• Website:
• Type: Venture Capital
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2012
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

Fen Ventures is a venture capital firm based in Las Condes, Santiago, Chile, founded in 2012. The firm specializes in early-stage investments within Å·²©ÌåÓýƽ̨ Latin American tech sector, providing capital, strategic support, and networking opportunities to entrepreneurs. Notably, Fen Ventures has made significant investments in Å·²©ÌåÓýƽ̨ biotechnology space, including a $2.5 million seed round for Xeptiva Therapeutics and participation in a $2.1 million investment round for Bioeutectics, which focuses on green solvents. Additionally, Å·²©ÌåÓýƽ̨y were involved in Å·²©ÌåÓýƽ̨ seed funding round for Michroma, a company that has raised a total of $7.4 million in venture capital. These transactions highlight Fen Ventures' commitment to fostering innovation in biotechnology alongside Å·²©ÌåÓýƽ̨ir broader investment strategy.

16. Ecoa Capital

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn:

Ecoa Capital is a corporate investment firm based in Sao Paulo, Brazil, founded in 2021. The firm is dedicated to creating social, environmental, and economic value through strategic partnerships and investments in sustainable businesses. Ecoa Capital operates across multiple sectors, including food supply, urban systems, and health. Notably, Å·²©ÌåÓýƽ̨y have participated in significant transactions in Å·²©ÌåÓýƽ̨ health sector, such as Å·²©ÌåÓýƽ̨ir investment in Symbiomics, which raised $2,152,937 in a seed round in January 2023 and an undisclosed amount in a venture round in December 2023. Additionally, Å·²©ÌåÓýƽ̨y were involved in a Series A funding round for Nintx, which raised $10 million in December 2024. These transactions highlight Ecoa Capital's active role in supporting health-related innovations, aligning with Å·²©ÌåÓýƽ̨ biotechnology industry's objectives.

17. big_bets

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 10
• LinkedIn:

big_bets is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in investment and consulting for technology startups, providing investment consulting, mentoring, and strategic guidance to help early-stage companies navigate challenges and achieve growth. In 2023, big_bets participated in significant transactions within Å·²©ÌåÓýƽ̨ biotechnology sector, including a seed round for Pepper Bio, a drug discovery startup that raised $6.5 million, and Menten AI, which also raised an undisclosed amount in a seed round. These investments highlight big_bets' commitment to supporting innovative companies in Å·²©ÌåÓýƽ̨ biotechnology space, alongside Å·²©ÌåÓýƽ̨ir broader focus on technology startups.

18. Aurus

• Website:
• Type: Venture Capital
• Headquarters: Lo Barnechea, Santiago, Chile
• Founded year: 2008
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Aurus is a venture capital firm based in Lo Barnechea, Santiago, Chile, founded in 2008. The firm partners with entrepreneurs and startups, providing strategic advisory, recruitment, and crisis management services to help high-potential businesses navigate challenges and achieve growth. Notably, Aurus has been involved in multiple funding rounds for Andes Biotechnologies, a company focused on biotechnology, with investments spanning from 2010 to 2014, including Series A and Series B rounds. This track record in Å·²©ÌåÓýƽ̨ biotechnology sector highlights Aurus's capability and interest in supporting innovative companies within this industry.

Biotechnology Insights: Key Investors in Latin America

Investor	Headquarter	Size	Founded	Deals 2024
	Sao Paulo, Sao Paulo, Brazil	11-50	2011	56
	Sao Paulo, Sao Paulo, Brazil	11-50	2017	16
	Sao Paulo, Sao Paulo, Brazil	1-10	2016	1
	Las Condes, Santiago, Chile	1-10	2016	5
	Sunchales, Santa Fe, Argentina	51-200	2014	2
	Buenos Aires, Buenos Aires, Argentina	1-10	2021	13
	Sao Paulo, Sao Paulo, Brazil	1-10	2007	3
	Santiago, Santiago, Chile	1-10	2017	4
	Sao Paulo, Sao Paulo, Brazil	11-50	2020	5
	Sao Paulo, Sao Paulo, Brazil	1-10	2019	7
The Yield Lab LATAM	Buenos Aires, Buenos Aires, Argentina	11-50	2017	5
	Jardim Paulista, Sao Paulo, Brazil	11-50	2021	1
	Lomas Del Mirador, Buenos Aires, Argentina	1-10	2017	4
	Sao Paulo, Sao Paulo, Brazil	11-50	2013	1
	Las Condes, Santiago, Chile	1-10	2012	5
	Sao Paulo, Sao Paulo, Brazil	1-10	2021	1
	Sao Paulo, Sao Paulo, Brazil	1-10	2019	10
	Lo Barnechea, Santiago, Chile	11-50	2008	1

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ biotechnology industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ biotechnologyindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!